Literature DB >> 15947556

Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping.

Werner Van Steenbergen1, Eric De Goede, Marie-Paule Emonds, Judith Reinders, Marcel Tilanus, Johan Fevery.   

Abstract

Immune mechanisms play a role in the pathogenesis of primary sclerosing cholangitis (PSC), as suggested by its association with certain HLA haplotypes. Genetic predisposition is supported by its occurrence in families, but data are scarce. Our aim is to report on two brothers with PSC, and to investigate HLA and MICA alleles in this family. The clinical, biochemical, radiological, and pathological findings in two brothers with PSC as well as in their sister and parents were reviewed. Molecular genotyping of HLA class II and MICA alleles was performed in all five family members. In two brothers, p-ANCA positive PSC was found. The youngest also had ulcerative colitis, and had evolved into cirrhosis at the age of 17 years. Their mother had positive p-ANCA and mild cholestatic changes. Their father and sister were unaffected. Both brothers were homozygous for the MICA*00801 allele, and were positive for the susceptibility HLA haplotypes DR3-DQ2 and DR6-DQ6. Their unaffected father and sister both carried the protective DR4 allele. The presence of PSC in two brothers, and the distribution of HLA haplotypes and MICA alleles, adds supportive evidence for an immunogenetic origin of PSC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947556     DOI: 10.1097/00042737-200507000-00013

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Autoimmune sclerosing cholangitis in two sisters.

Authors:  Valerio Nobili; Rita Devito; Luigi Dall'oglio; Francesca Cainelli; Paola Giustiniani; Elia Girolami; Matilde Marcellini
Journal:  Eur J Pediatr       Date:  2007-01-06       Impact factor: 3.183

Review 2.  NK cell autoreactivity and autoimmune diseases.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2014-02-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.